Your browser doesn't support javascript.
loading
Longitudinal characterization of patients with progressive apraxia of speech without clearly predominant phonetic or prosodic speech features.
Utianski, Rene L; Meade, Gabriela; Duffy, Joseph R; Clark, Heather M; Botha, Hugo; Machulda, Mary M; Dickson, Dennis W; Whitwell, Jennifer L; Josephs, Keith A.
Afiliação
  • Utianski RL; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: Utianski.Rene@mayo.edu.
  • Meade G; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Duffy JR; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Clark HM; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Botha H; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Machulda MM; Department of Psychology and Psychiatry, Mayo Clinic, Rochester, MN, USA.
  • Dickson DW; Department of Neuroscience, Mayo Clinic, FL, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Brain Lang ; 245: 105314, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37607419
ABSTRACT
Most recent studies of progressive apraxia of speech (PAOS) have focused on patients with phonetic or prosodic predominant PAOS to understand the implications of the presenting clinical phenotype. Patients without a clearly predominating speech quality, or mixed AOS, have been excluded. Given the implications for disease progression, it is important to understand these patients early in the disease course to inform appropriate education and prognostication. The aim of this study was to describe a cohort of ten patients with initially mixed PAOS and how their clinical course evolves. Four patients were rated prosodic predominant later on (mild AOS at first visit); five were later designated phonetic (four with more than mild AOS at first visit); one was judged mixed at all visits. The study suggests patients without a clear predominance of speech featuresshould still be included in PAOS studies and thought of on the continuum of the disease spectrum.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article